(Q33543723)

English

Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

0 references

expanded access

1 reference

based on heuristic

inferred from title

multiple myeloma

1 reference

based on heuristic

inferred from title

author name string

R F Duarte

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

B E Shaw

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

P Marín

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

P Kottaridis

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

M Ortiz

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

C Morante

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

J Delgado

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

J Gayoso

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

R Goterriz

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

C Martínez-Chamorro

10

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

J J Mateos-Mazón

11

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

C Ramírez

12

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

J de la Rubia

13

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

H Achtereekte

14

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

P J Gandhi

15

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

K W Douglas

16

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

N H Russell

17

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

0 references

publication date

22 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

52-58

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Trends of hematopoietic stem cell transplantation in the third millennium

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

21 January 2018

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

21 January 2018

Defining a Therapeutic Dose of Peripheral Blood Stem Cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

21 January 2018

High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

21 January 2018

Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

21 January 2018

CXCR4 and mobilization of hematopoietic precursors.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

21 January 2018

Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantatio

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

21 January 2018

Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

21 January 2018

AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

21 January 2018

Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

21 January 2018

Second attempts at mobilization of peripheral blood stem cells in patients with initial low CD34+ cell yields

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

21 January 2018

Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

21 January 2018

Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

21 January 2018

Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

21 January 2018

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

7 January 2021

based on heuristic

inferred from DOI database lookup

The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

7 January 2021

based on heuristic

inferred from DOI database lookup

Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

7 January 2021

based on heuristic

inferred from DOI database lookup

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.54

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2010.54

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33543723&oldid=2195471190"